Equitable Allocation of COVID-19 Vaccines

The National Academies of Sciences, Engineering, and Medicine will soon announce a public comment period for a forthcoming study on Equitable Allocation of Vaccines Against COVID-19. The study is sponsored by NIH and CDC and will recommend criteria to help policymakers set priorities for the allocation of a limited initial supply of COVID-19 vaccine, when available. Public input, especially from groups highly impacted by COVID-19, is essential to inform this study. For more information, visit the study webpage and sign up for the COVID-19 & Infectious Diseases listserve to be notified when the public comment period opens.